AstraZeneca PLC ADR

AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.

$76.70
(as of Oct 23, 11:33 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for AstraZeneca PLC ADR

Stock Price
$76.70
Ticker Symbol
AZN
Exchange
NASDAQ

Industry Information for AstraZeneca PLC ADR

Sector
Healthcare
Industry
Drug Manufacturers - General

Company Description for AstraZeneca PLC ADR

Country
USA
Full Time Employees
89,900

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Fundamentals for AstraZeneca PLC ADR

Market Capitalization
$242,652,184,576
EBITDA
$16,972,999,680
Dividends per Share
$2.97
P/E Ratio
37.99
Forward P/E Ratio
16.5
Earnings per Share
$2.06
Earnings per Share Estimate Next Year
$5.49
Profit Margin
13.11%
Shares Outstanding
3,100,590,080
Percent Owned by Insiders
0.01%
Percent Owned by Institutions
17.06%
52-Week High
$87.68
52-Week Low
$59.19

Technical Indicators for AstraZeneca PLC ADR

50-Day Moving Average
$81.00
200-Day Moving Average
$74.49
RSI
42.18
0.93

Analyst Ratings for AstraZeneca PLC ADR

Strong Buy
6
Buy
3
Hold
2
Sell
0
Strong Sell
0

News About AstraZeneca PLC ADR

Oct 21, 2024, 2:03 AM EST
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic uncertainties. See more.
Oct 20, 2024, 3:06 AM EST
Key Insights See more.
Oct 17, 2024, 1:59 PM EST
We recently published a list of 8 High Growth UK Stocks to Invest In. See more.
Oct 17, 2024, 8:15 AM EST
For Immediate Release See more.